Table 4.
Univariate and multivariate logistic regression analysis between the training and validation cohorts
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | |
| Age | 1.02 (0.98–1.05) | 0.307 | ||
| Gender | ||||
| Female | Reference | |||
| Male | 1.37 (0.62–3.01) | 0.437 | ||
| BMI | 1.12 (1.01–1.26) | 0.047 | 1.52 (1.10–2.11) | 0.011 |
| ASA | ||||
| 2 | Reference | |||
| 3 | 0.34 (0.12–0.97) | 0.044 | 0.64 (0.10–4.27) | 0.642 |
| 1 | 0.82 (0.26–2.56) | 0.730 | 1.86 (0.28–12.36) | 0.52 |
| Hypertension | ||||
| Yes | Reference | |||
| No | 0.14 (0.06–0.32) | < 0.001 | 0.20 (0.05–0.87) | 0.032 |
| Preoperative hemoglobin | 1.00 (0.98–1.02) | 0.886 | ||
| Preoperative serum albumin | ||||
| ≥ 35 g/L | Reference | |||
| <35 g/L | 5.75 (2.33–14.21) | < 0.001 | 5.10 (0.91–28.60) | 0.064 |
| Preoperative total cholesterol | 0.87 (0.54–1.40) | 0.565 | ||
| Preoperative triglyceride | 1.61 (0.89–2.88) | 0.112 | ||
| Preoperative C -reactive protein count | 1.00 (0.99–1.02) | 0.759 | ||
| SAT area | 1.01 (1.01–1.01) | 0.045 | 1.02 (1.01–1.04) | 0.013 |
| SAT Radiodensity | 0.96 (0.91–1.01) | 0.098 | ||
| VAT Radiodensity | 1.12 (1.06–1.18) | < 0.001 | 1.34 (1.16–1.56) | < 0.001 |
| Distance between tumor and the dentate line | ||||
| <10 cm | Reference | |||
| ≥ 10 cm | 0.13 (0.05–0.32) | < 0.001 | 0.03 (0.01–0.21) | < 0.001 |
| SIG | ||||
| 3 | Reference | |||
| 0 | 2.50 (0.28–22.40) | 0.413 | ||
| 1 | 1.20 (0.12–12.27) | 0.878 | ||
| 2 | 0.83 (0.04–16.99) | 0.906 | ||
| Tumor diameter | ||||
| >3 cm | Reference | |||
| ≤ 3 cm | 0.10 (0.03–0.30) | < 0.001 | 0.14 (0.03–0.82) | 0.029 |
| Diabetes | ||||
| No | Reference | |||
| Yes | 1.30 (0.37–4.62) | 0.682 | ||
BMI body mass index; ASA American Society of Anesthesiologists; SAT subcutaneous fatty tissue; VAT visceral adipose tissue; SIG Systemic Inflammatory Grade